Tuesday, 12 July 2022

Plant Cell Biology Company Already In Commercialization

 

Plant Cell Biology Company Already In Commercialization

This global leader in plant cell biology enters commercialization and has a pipeline of 6 major customers for its products. Q2 sales orders set a new high at 97% growth over Q2 2021. Leveraging their patented platform technology, this company is poised to bring the next generation of science-based therapeutics to the world. 

ADD THIS COMPANY TO YOUR WATCHLIST! 

A Bigger Opportunity For Growth...

A smaller stock with a relatively low market cap often outperforms a larger company stock with a much higher market cap... And when an investor is spending fewer dollars for a stock purchase there's a bigger opportunity for growth.

Click Here for Our Top 5 Microcap Stocks 


* Biggest American Mega Boom in 175 Years...Click here to take a look.  [AD]

* FREE! The Ultimate Dividend Package [AD]

* Deep Dive: These High-Yield Stocks Are Down As Much As 58% This Year. But Their Inflation-Fighting Dividends Have Room To Grow.

Stockguru LLC
711 SW 24th Ave Boynton, Beach, FL 33435

This email is being sent from Investing Chatter.
If you no longer wish to receive Investing Chatter emails, please click to unsubscribe.
DISCLAIMER: Stocks and options trading have large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the stocks and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell stocks or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed in this report. The past performance of any trading system or methodology is not necessarily indicative of future results. All trades, patterns, charts, systems, etc., discussed in this report are for illustrative purposes only and not to be construed as specific advisory recommendations. Information contained in this correspondence is intended for informational purposes only and was obtained from sources believed to be reliable. Information is in no way guaranteed. No guarantee of any kind is implied or possible where projections of future conditions are attempted.

No comments:

Post a Comment

Breaking News Hits Wire: TC BioPharm (NASDAQ: TCBP) Makes Approx 189% Early Move

  *Sponsored After an Approximate 1,041% Move in Under 3 Months From a Recent BioPharma Profile, Ou...